(Q34087196)

30 July 2017

title

Radiation necrosis following treatment of high grade glioma--a review of the literature and current understanding (English)

1 reference

30 July 2017

Alan Siu

1

1 reference

30 July 2017

Joshua J Wind

2

1 reference

30 July 2017

J Bryan Iorgulescu

3

1 reference

30 July 2017

Timothy A Chan

4

1 reference

30 July 2017

Yoshiya Yamada

5

1 reference

30 July 2017

Jonathan H Sherman

6

1 reference

30 July 2017

publication date

1 December 2011

1 reference

30 July 2017

1 reference

30 July 2017

volume

154

1 reference

30 July 2017

issue

2

1 reference

30 July 2017

page(s)

191-201; discussion 201

1 reference

https://scigraph.springernature.com/pub.10.1007/s00701-011-1228-6

30 July 2017

exact match

0 references

cites work

Prostaglandin E1 in lipid microspheres ameliorates diabetic peripheral neuropathy: clinical usefulness of Semmes-Weinstein monofilaments for evaluating diabetic sensory abnormality

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1228-6

Anti-TNFA (TNF-alpha) treatment abrogates radiation-induced changes in vacular density and tissue oxygenation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1228-6

Dynamic susceptibility contrast MRI of gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1228-6

Oxidants and antioxidants: state of the art.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1228-6

Radiation induced CNS toxicity--molecular and cellular mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1228-6

Diffusion weighted imaging in radiation necrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1228-6

Irradiated volume as a predictor of brain radionecrosis after linear accelerator stereotactic radiosurgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1228-6

Temozolomide concomitant and adjuvant to radiotherapy in elderly patients with glioblastoma: correlation with MGMT promoter methylation status.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1228-6

MGMT promoter methylation status can predict the incidence and outcome of pseudoprogression after concomitant radiochemotherapy in newly diagnosed glioblastoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1228-6

Recurrence pattern after temozolomide concomitant with and adjuvant to radiotherapy in newly diagnosed patients with glioblastoma: correlation With MGMT promoter methylation status

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1228-6

Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1228-6

Pseudoprogression and pseudoresponse in the treatment of gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1228-6

The efficacy of hyperbaric oxygen therapy in the treatment of radiation-induced late side effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1228-6

The correlation and prognostic significance of MGMT promoter methylation and MGMT protein in glioblastomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1228-6

Perfusion, diffusion and spectroscopy values in newly diagnosed cerebral gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1228-6

Temozolomide-mediated radiation enhancement in glioblastoma: a report on underlying mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1228-6

Early necrosis following concurrent Temodar and radiotherapy in patients with glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1228-6

The sensitivity and specificity of FDG PET in distinguishing recurrent brain tumor from radionecrosis in patients treated with stereotactic radiosurgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1228-6

Delayed molecular responses to brain irradiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1228-6

Temporal lobe necrosis following radiation therapy for nasopharyngeal carcinoma: 1H MR spectroscopic findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1228-6

Temporal lobe changes following radiation therapy: imaging and proton MR spectroscopic findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1228-6

Hyperbaric oxygen therapy for radiation-induced brain injury in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1228-6

Dynamic magnetic resonance perfusion imaging of brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1228-6

Neurobehavioral sequelae of cranial irradiation in adults: a review of radiation-induced encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1228-6

Immediate post-radiotherapy changes in malignant glioma can mimic tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1228-6

Positron emission tomography with injection of methionine as a prognostic factor in glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1228-6

Cerebral necrosis after radiotherapy and/or intraarterial chemotherapy for brain tumors: PET and neuropathologic studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1228-6

Upregulation of intercellular adhesion molecule-1 expression on human endothelial cells by tumour necrosis factor-alpha in an in vitro model of the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1228-6

MGMT promoter methylation correlates with survival benefit and sensitivity to temozolomide in pediatric glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1228-6

Canadian recommendations for the treatment of recurrent or progressive glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1228-6

Role of perfusion CT in glioma grading and comparison with conventional MR imaging features.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1228-6

Differences in ICAM-1 and TNF-alpha expression between large single fraction and fractionated irradiation in mouse brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1228-6

Identification of early recurrence of primary central nervous system tumors by [18F]fluorodeoxyglucose positron emission tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1228-6

Diagnostic accuracy of 201Thallium-SPECT and 18F-FDG-PET in the clinical assessment of glioma recurrence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1228-6

Effect of bevacizumab on radiation necrosis of the brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1228-6

Transient early computed tomographic changes mimicking tumor progression after brain tumor irradiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1228-6

Clinical trial substantiates the predictive value of O-6-methylguanine-DNA methyltransferase promoter methylation in glioblastoma patients treated with temozolomide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1228-6

MGMT gene silencing and benefit from temozolomide in glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1228-6

Brain tumor imaging in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1228-6

Normalizing tumor vasculature with anti-angiogenic therapy: a new paradigm for combination therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1228-6

Tumor angiogenesis and accessibility: role of vascular endothelial growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1228-6

Effect of vascular normalization by antiangiogenic therapy on interstitial hypertension, peritumor edema, and lymphatic metastasis: insights from a mathematical model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1228-6

Exacerbation of cerebral radiation necrosis by bevacizumab.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1228-6

Diffusion tensor imaging for differentiation of recurrent brain tumor and radiation necrosis after radiotherapy--three case reports.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1228-6

Differentiation of residual or recurrent tumors from post-treatment changes with F-18 FDG PET

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1228-6

Successful treatment of radiation-induced brain necrosis by hyperbaric oxygen therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1228-6

Combined modality therapy of operated astrocytomas grade III and IV. Confirmation of the value of postoperative irradiation and lack of potentiation of bleomycin on survival time: a prospective multicenter trial of the Scandinavian Glioblastoma Stud

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1228-6

Malignant gliomas: MR imaging spectrum of radiation therapy- and chemotherapy-induced necrosis of the brain after treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1228-6

Cyclooxygenase-2 modulates brain inflammation-related gene expression in central nervous system radiation injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1228-6

Factors affecting risk of symptomatic temporal lobe necrosis: significance of fractional dose and treatment time

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1228-6

Randomized double-blind placebo-controlled trial of bevacizumab therapy for radiation necrosis of the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1228-6

Metabolic imaging to follow stereotactic radiation of gliomas -- the role of 1H MR spectroscopy in comparison to FDG-PET and IMT-SPECT

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1228-6

Experimental evidence to support the hypothesis that damage to vascular endothelium plays the primary role in the development of late radiation-induced CNS injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1228-6

Response criteria for phase II studies of supratentorial malignant glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1228-6

Arrested neuronal proliferation and impaired hippocampal function following fractionated brain irradiation in the adult rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1228-6

Cerebral radionecrosis: Incidence and risk in relation to dose, time, fractionation and volume

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1228-6

Reirradiation tolerance of the human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1228-6

Cellular mechanisms by which tumor necrosis factor-alpha produces disruption of the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1228-6

The positive predictive value of O-(2-[18F]fluoroethyl)-L-tyrosine (FET) PET in the diagnosis of a glioma recurrence after multimodal treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1228-6

Irradiation induces neural precursor-cell dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1228-6

Inflammatory Blockade Restores Adult Hippocampal Neurogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1228-6

Radiation-induced edema is dependent on cyclooxygenase 2 activity in mouse brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1228-6

Intercellular adhesion molecule-1 and blood-spinal cord barrier disruption in central nervous system radiation injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1228-6

Effect of prophylactic hyperbaric oxygen treatment for radiation-induced brain injury after stereotactic radiosurgery of brain metastases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1228-6

The use of PET in evaluating patients with primary brain tumours: is it useful?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1228-6

ICAM-1 induction in the mouse CNS following irradiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1228-6

123I-IMT SPECT and 1H MR-spectroscopy at 3.0 T in the differential diagnosis of recurrent or residual gliomas: a comparative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1228-6

Value of O-(2-[18F]fluoroethyl)- L-tyrosine PET for the diagnosis of recurrent glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1228-6

In vivo 3-T MR spectroscopy in the distinction of recurrent glioma versus radiation effects: initial experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1228-6

Positron emission tomography with O-(2-[18F]fluoroethyl)-l-tyrosine versus magnetic resonance imaging in the diagnosis of recurrent gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1228-6

Development of blood vessel-related radiation damage in the fimbria of the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1228-6

MGMT promoter methylation is predictive of response to radiotherapy and prognostic in the absence of adjuvant alkylating chemotherapy for glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1228-6

Associations among magnetic resonance spectroscopy, apparent diffusion coefficients, and image-guided histopathology with special attention to radiation necrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1228-6

Cerebrovascular complications in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1228-6

Cerebral radiation necrosis: incidence, outcomes, and risk factors with emphasis on radiation parameters and chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1228-6

A randomized study of chemotherapy with procarbazine, vincristine, and lomustine with and without radiation therapy for astrocytoma grades 3 and/or 4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1228-6

Acid sphingomyelinase-deficient human lymphoblasts and mice are defective in radiation-induced apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1228-6

Association of Crohn's disease and latent celiac disease: a case report and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1228-6

Differentiation of radiation necrosis from tumor progression using proton magnetic resonance spectroscopy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1228-6

Radiation response of the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1228-6

Treatment of malignant glioma. A controlled study of chemotherapy and irradiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1228-6

Conservative treatment of delayed cerebral radiation necrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1228-6

Developing a clinical decision model: MR spectroscopy to differentiate between recurrent tumor and radiation change in patients with new contrast-enhancing lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1228-6

Serial diffusion-weighted magnetic resonance imaging in cases of glioma: distinguishing tumor recurrence from postresection injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1228-6

Delayed adverse effects after irradiation of gliomas: clinicopathological analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1228-6

Clinical usefulness of 11C-MET PET and 201T1 SPECT for differentiation of recurrent glioma from radiation necrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1228-6

Response criteria for glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1228-6

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1228-6

TNF-alpha activation of arterioles and venules alters distribution and levels of ICAM-1 and affects leukocyte-endothelial cell interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1228-6

Differentiation of recurrent brain tumor versus radiation injury using diffusion tensor imaging in patients with new contrast-enhancing lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1228-6

Incidence of early pseudo-progression in a cohort of malignant glioma patients treated with chemoirradiation with temozolomide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1228-6

Diagnostic accuracy of 11C-methionine PET for differentiation of recurrent brain tumors from radiation necrosis after radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1228-6

The radioresponse of the central nervous system: a dynamic process

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1228-6

Initial experience with bevacizumab treatment for biopsy confirmed cerebral radiation necrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1228-6

Methionine positron emission tomography of recurrent metastatic brain tumor and radiation necrosis after stereotactic radiosurgery: is a differential diagnosis possible?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1228-6

Methionine positron emission tomography for differentiation of recurrent brain tumor and radiation necrosis after stereotactic radiosurgery--in malignant glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1228-6

PET of malignant cerebral tumors after interstitial brachytherapy. Demonstration of metabolic activity and correlation with clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1228-6

End point assessment in gliomas: novel treatments limit usefulness of classical Macdonald's Criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1228-6

Repair capacity of adult rat glial progenitor cells determined by an in vitro clonogenic assay after in vitro or in vivo fractionated irradiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1228-6

Radiosensitivity of glial progenitor cells of the perinatal and adult rat optic nerve studied by an in vitro clonogenic assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1228-6

Direct comparison of 18F-FDG and 11C-methionine PET in suspected recurrence of glioma: sensitivity, inter-observer variability and prognostic value

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1228-6

Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1228-6

Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1228-6

Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1228-6

Radiation-induced astrogliosis and blood-brain barrier damage can be abrogated using anti-TNF treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1228-6

Mechanisms of radiation injury to the central nervous system: implications for neuroprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1228-6

Bevacizumab reverses cerebral radiation necrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1228-6

New advances that enable identification of glioblastoma recurrence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1228-6

Pathological review of late cerebral radionecrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1228-6

Effects of fractionated radiation on the brain vasculature in a murine model: blood-brain barrier permeability, astrocyte proliferation, and ultrastructural changes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1228-6

Radiation-induced permeability and leukocyte adhesion in the rat blood-brain barrier: modulation with anti-ICAM-1 antibodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1228-6

Multivoxel 3D proton MR spectroscopy in the distinction of recurrent glioma from radiation injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1228-6

Inflammation and chronic oxidative stress in radiation-induced late normal tissue injury: therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1228-6

Epigenetic inactivation of LKB1 in primary tumors associated with the Peutz-Jeghers syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1228-6

10.1007/S00701-011-1228-6

21 January 2018

Identifiers

DOI

1 reference

30 July 2017

1 reference